359
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

VEGF expression and microvascular density in relation to high-risk-HPV infection in cervical carcinoma – An immunohistochemical studyFootnoteFootnote

, &
Pages 47-57 | Received 01 Nov 2011, Accepted 20 Dec 2011, Published online: 17 May 2019

References

  • F.X.BoschA.LorinczN.MuñozC.J.MeijerK.V.ShahThe causal relation between human papillomavirus and cervical cancerJ Clin Pathol5542002244265
  • Elattar IA. Cancer statistics at National Cancer Institute, Cairo; 2002–2003: Cancer statistics for specific site; cancers of female genital system. Available at: <http://www.nci.edu.eg/lectures/NCI/registry2002-2003.doc> [last accessed 10.10.2011].
  • WHO histological classification of tumours of the uterine cervix. Available at: <http://www.screening.iarc.fr/atlasclassifwho.php>. [last accessed 16.10.2011].
  • A.J.TiltmanThe pathology of cervical tumoursBest Pract Res Clin Obstet Gynaecol1942005485500
  • I.I.KesslerHuman cervical cancer as a venereal diseaseCancer Res3619767891
  • R.D.BurkZ.ChenK.Van DoorslaerHuman papillomaviruses: genetic basis of carcinogenicityPublic Health Genomics125-62009281290
  • H.Zur HausenPapillomaviruses in human cancersProc Assoc Am Physicians1111999581587
  • N.MunozF.X.BoschS.de Sanjose’Epidemiologic classification of human papillomavirus types associated with cervical cancerN Engl J Med3482003518528
  • M.StanleyPathology and epidemiology of HPV infection in femalesGynecol Oncol1172l2010S5S10
  • N.WentzensenS.J.KlugCervical cancer control in the era of HPV vaccination and novel biomarkersPathobiology76220098289
  • J.H.NoH.JoS.H.KimI.A.ParkD.KangS.S.HanExpression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasiaAnn N Y Acad Sci11712009105110
  • E.Toussaint-SmithD.B.DonnerA.RomanExpression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factorsOncogene23200429882995
  • R.RibattiThe crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical reviewBr J Haematol12832005303309
  • M.KirshM.A.DimopoulosAngiogenesis in human cancer: implications in cancer therapyEur J Int Med142003459469
  • H.F.DvorakRous-Whipple Award Lecture. How tumors make bad blood vessels and stromaAm J Pathol162200317471757
  • N.FerraraH.GerberJ.Le CouterThe biology of VEGF and its receptorsNat Med92003669676
  • G.D.YancopoulosS.DavisN.W.GaleJ.S.RudgeS.J.WiegandJ.HolashVascular-specific growth factors and blood vessel formationNature45112000242248
  • A.RiceC.M.QuinnAngiogenesis, thrombospondin, and ductal carcinoma in situ of the breastJ Clin Pathol552002569574
  • M.RaicaA.M.CimpeanD.RibattiAngiogenesis in pre-malignant conditionsEur J Cancer4511200919241934
  • A.DellasH.MochE.SchultheissG.FeichterA.C.AlmendralF.GudatAngiogenesis in cervical neoplasia: microvessels quantification in precancerous lesion and invasive carcinomas with clinicopathalogical correlationsGynecol Oncol6719972733
  • N.WeidnerJ.P.SempleW.R.WelchJ.FolkmanTumour angiogenesis and metastasis-correlation in invasive breast carcinomaN Eng J Med324199118
  • J.PatardN.Rioux-LeclercqP.FergelotUnderstanding the importance of smart drugs in renal cell carcinomaEur Urol492006633643
  • N.FerraraVascular endothelial growth factor as a target for anticancer therapyOncologist92004210
  • M.ToiT.MatsumotoH.BandoVascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsLancet Oncol22001667673
  • H.ZengH.F.DvorakD.MukhopadhyayVascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathwaysJ Biol Chem27620012696926979
  • N.FerraraRole of vascular endothelial growth factor in regulation of physiological angiogenesisAm J Physiol Cell Physiol280200113581366
  • A.C.BrodersCarcinoma: grading and practical applicationArch Pathol21962376
  • W.D.LawrenceF.W.Abdul-KarimC.CrumY.-S.FuRecommendations for the reporting of surgical specimens containing uterine cervical neoplasms. Grading adenocarcinomaMod Pathol134200010291033
  • K.J.O’ByrneM.I.KoukourakisA.GiatromanolakiG.CoxH.TurleyW.P.StewardVascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancerBr J Cancer82200014271432
  • J.L.CordellK.A.PulfordB.BigernaG.RoncardoA.BanhamE.ColomboDetection of normal and chimeric nucleophosmin in human cellsBlood931999632642
  • Y.EralpP.SaipB.SakarS.KucucukA.AydinerM.DincerPrognostic factors and survival in patients with metastasis or recurrent carcinoma of the cervixInt J Gynecol Cancer132003497504
  • D.ShweikiA.ItinD.SofferE.KeshetVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature3591992843845
  • G.L.BremerA.T.TieboschH.M.Van der PuttenH.J.SchoutenJ.De HaanJ.W.ArendsTumor angiogenesis: an independent prognosis parameter in cervical cancerAm J Obstet Gynecol1741996126131
  • F.T.CuttsS.FranceschiS.GoldieX.CastellsagueS.de SanjoseG.GarnettHuman papillomavirus and HPV vaccines: a reviewBull World Health Organ8592007719726
  • WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in Egypt. Summary Report 2010. Available at: <http://www.who.int/hpvcentre> [accessed 10.10.2011].
  • V.M.NagyR.BuigaI.BrieN.TodorO.TudoranC.OrdeanuExpression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapyRom J Morphol Embryol5220115359
  • D.De LeónC.Lopez-GranielM.Frias MendivilG.Chanona VilchisC.GomezJ.De La Garza SalazarSignificance of microvascular density (MVD) in cervical cancer recurrenceInt J Gynecol Cancer132003856862
  • D.K.GaffneyD.HaslamA.TsodikovE.HammondJ.SeamanJ.HoldenEpidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapyInt J Radiat Oncol Biol Phys5642003922928
  • J.S.LeeH.S.KimJ.T.ParkM.C.LeeC.S.ParkExpression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 statusAnal Quant Cytol Histol2562003303311
  • L.Y.DirixP.B.VermeulenA.PawinskiA.ProvéI.BenoyC.De PooterElevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patientsBr J Cancer761997238243
  • J.FujimotoH.SakaguchiR.HiroseS.IchigoT.TamayaExpression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancersBr J Cancer801999827833
  • T.A.BrockH.F.DvorakD.R.SengerTumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cellsAm J Pathol1381991213221
  • Y.DaiX.ZhangY.PengZ.WangThe expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinomaGynecol Oncol97200596103
  • G.SouflaS.SifakisS.BaritakiA.ZafiropoulosE.KoumantakisD.A.SpandidosVEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervixCancer Lett2212005105118
  • K.TokumoJ.KodamaN.SekiY.NakanishiY.MiyagiS.KamimuraDifferent angiogenic pathways in human cervical cancersGynecol Oncol6819983844
  • S.KuemmelA.ThomasS.LandtA.FugerP.SchmidM.KrinerCirculating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancerAnticancer Res292009641646
  • N.MuñozF.X.BoschS.de SanjoséR.HerreroX.CastellsaguéK.V.ShahEpidemiologic classification of human papillomavirus types associated with cervical cancerN Engl J Med3482003518527
  • I.J.LeeK.R.ParkK.K.LeeJ.S.SongK.G.LeeJ.Y.LeePrognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervixInt J Radiat Oncol Biol Phys542002768779
  • H.K.HauglandV.VukovicM.PintilieA.W.FylesM.MilosevicR.P.HillExpression of hypoxia-inducible factor-1 α in cervical carcinomas: correlation with tumor oxygenationInt J Radiat Oncol Biol Phys532002854861
  • W.TjalmaJ.WeylerB.WeynE.Van MarckA.Van DaeleP.Van DamThe association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancerEur J Obstet Gynecol Reprod Biol9222000251257
  • M.NeemanR.AbramovitchY.S.SchiffenbauerC.TempelRegulation of angiogenesis by hypoxic stress: from solid tumours to ovarian follicleInt J Exp Pathol7819975770
  • L.F.BrownB.BerseR.W.JackmanK.TognazziA.J.GuidiH.F.DvorakExpression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancerHum Pathol2619958691
  • H.F.DvorakL.F.BrownM.DetmarA.M.DvorakVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesisAm J Pathol146199510291039
  • M.MiettinenA.E.LindenmayerA.ChaubalEndothelial cell markers CD31, CD34 and BNH9 antibody to H- and Y-antigens – evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factorMod Pathol119948290
  • I.KuzuR.BicknellA.L.HarrisM.JonesK.C.GatterD.Y.MasonHeterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumorsJ Clin Pathol451992143148
  • S.Di LeoS.CaschettoG.GarozzoG.NuciforoN.CassaroM.T.MeliAngiogenesis as a prognostic factor in cervical carcinomaEur J Gynaecol Oncol191998158162
  • W.F.ChengC.N.LeeJ.S.ChuC.A.ChenT.M.ChenW.Y.ShauVascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinomaCancer851999651657
  • J.S.ParkE.J.KimH.J.KwonE.S.HwangS.E.NamkoongS.J.UmInactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesisJ Biol Chem275200067646769
  • A.M.De Roda HusmanJ.M.WalboomersE.HopmanO.P.BlekerT.M.HelmerhorstL.RozendaalHPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related patternJ Med Virol46199597102
  • C.UngureanuD.SocolovG.AntonM.S.MihailoviciS.TelemanImmunocytochemical expression of p16INK4a and HPV L1 capsid proteins as predictive markers of the cervical lesions progression riskRom J Morphol Embryol5132010497503
  • K.LalaouiM.El MzibriM.AmraniM.A.BelabbasP.A.LazoHuman papillomavirus DNA in cervical lesions from Morocco and its implications for cancer controlClin Microbiol Infect922003144148
  • S.MortazaviM.ZaliM.RaoufiM.NadjiP.KowsarianA.NowrooziThe prevalence of human papillomavirus in cervical cancer in IranAsian Pac J Cancer Prev3120026972
  • G.M.CliffordJ.S.SmithM.PlummerN.Mun˜ozS.FranceschiHuman papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBr J Cancer8820036373
  • H.S.el-AllA.RefaatK.DandashPrevalence of cervical neoplastic lesions and human papilloma virus infection in Egypt: National Cervical Cancer Screening ProjectInfect Agent Cancer42007212
  • J.M.WalboomersM.V.JacobsM.M.ManosF.X.BoschJ.A.KummerK.V.ShahHuman papillomavirus is a necessary cause of invasive cervical cancer worldwideJ Pathol189119991219
  • G.CliffordS.FranceschiM.DiazN.MuñozL.L.VillaChapter 3: HPV type-distribution in women with and without cervical neoplastic diseasesVaccine24Suppl. 320062634
  • A.YemelyanovaR.VangJ.D.SeidmanP.E.GravittB.M.RonnettEndocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumorAm J Surg Pathol332009914924
  • S.H.SongJ.K.LeeJ.Y.HurI.KimH.S.SawY.K.ParkThe expression of epidermal growth factor receptor, vascular endothelial growth factor, matrix metalloproteinase-2, and cyclooxygenase-2 in relation to human papilloma viral load and persistence of human papillomavirus after conization with negative marginsInt J Gynecol Cancer166200620092017
  • O.López-OcejoA.Viloria-PetitM.Bequet-RomeroD.MukhopadhyayJ.RakR.S.KerbelOncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent mannerOncogene19200046114620
  • M.Bequet-RomeroO.Lopez-OcejoAngiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteinsBiochem Biophys Res Commun27720005561
  • S.H.KimY.S.JuhnnS.KangS.W.ParkM.W.SungY.J.BangHuman papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/AktCell Mol Life Sci632006930938